Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3356600
Max Phase: Preclinical
Molecular Formula: C34H50N10O5S
Molecular Weight: 710.91
Molecule Type: Protein
Associated Items:
ID: ALA3356600
Max Phase: Preclinical
Molecular Formula: C34H50N10O5S
Molecular Weight: 710.91
Molecule Type: Protein
Associated Items:
Canonical SMILES: CC(=O)N[C@@H](Cc1c[nH]c2ccccc12)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)c1nccs1
Standard InChI: InChI=1S/C34H50N10O5S/c1-20(2)17-27(31(48)42-25(12-8-14-39-34(36)37)29(46)33-38-15-16-50-33)44-30(47)26(11-6-7-13-35)43-32(49)28(41-21(3)45)18-22-19-40-24-10-5-4-9-23(22)24/h4-5,9-10,15-16,19-20,25-28,40H,6-8,11-14,17-18,35H2,1-3H3,(H,41,45)(H,42,48)(H,43,49)(H,44,47)(H4,36,37,39)/t25-,26-,27-,28-/m0/s1
Standard InChI Key: UNOVDKDICJRWRT-LJWNLINESA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 710.91 | Molecular Weight (Monoisotopic): 710.3686 | AlogP: 1.45 | #Rotatable Bonds: 21 |
Polar Surface Area: 250.07 | Molecular Species: BASE | HBA: 9 | HBD: 9 |
#RO5 Violations: 2 | HBA (Lipinski): 15 | HBD (Lipinski): 11 | #RO5 Violations (Lipinski): 3 |
CX Acidic pKa: 11.76 | CX Basic pKa: 11.52 | CX LogP: -0.14 | CX LogD: -4.62 |
Aromatic Rings: 3 | Heavy Atoms: 50 | QED Weighted: 0.03 | Np Likeness Score: -0.03 |
1. Han Z, Harris PK, Jones DE, Chugani R, Kim T, Agarwal M, Shen W, Wildman SA, Janetka JW.. (2014) Inhibitors of HGFA, Matriptase, and Hepsin Serine Proteases: A Nonkinase Strategy to Block Cell Signaling in Cancer., 5 (11): [PMID:25408834] [10.1021/ml500254r] |
Source(1):